In ER+ breast cancer cells, Bobowski et al., demonstrated that estradiol inhibits NF-κB-mediated activation by inhibition of p50/ p65 NF-κB subunit translocation into the nucleus, resulting in decreased GD3S expression [39]. This evidence concerns the gene NFKB1 and breast cancer.